An oncogenic mutation uncouples the v-Jun oncoprotein from positive regulation by the SAPK/JNK pathway in vivo

Current Biology

Volumn 8, Issue 2, 1998, Pages 117-120

  May, G H W ^a   Funk, M ^b,d   Black, E J ^a   Clark, W ^a   Hussain, S ^a   Woodgett, J R ^c   Gillespie, D A F ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c PRINCESS MARGARET HOSPITAL   (Canada)

^d MediGene AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

EID: 0032518334     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(98)70043-0     Document Type: Article

References (27)

1. Hibi M, Lin A, Smeal T, Minden A, Karin M: Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev 1993, 7:2135-2148.
2. Derijard B, Hibi M, Wu I, Barrett T, Su B, Deng T, et al.: JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994, 76:1025-1037.
3. Kallunki T, Deng, T, Hibi, M, Karin, M: c-Jun can recruit JNK to phosphorylate dimerisation partners via specific docking interactions. Cell 1996, 87:929-939.
4. Bos TJ, Monteclaro FS, Mitsunobu F, Ball AR, Chang CHW, Nishimura T, Vogt PK: Efficient transformation of chicken embryo fibroblasts by c-Jun requires structural modification in coding and non-coding sequences. Genes Dev 1990, 4:1677-1687.
5. Morgan IM, Havarstein LS, Wong W, Luu P, Vogt PK: Efficient induction of fibrosarcomas by v-Jun requires mutations in the DNA binding region and the transactivation domain. Oncogene 1994, 9:2793-2797.
6. Dai T, Rubie E, Franklin CC, Kraft A, Gillespie DAF, Avruch J, et al.: Stress-activated protein kinases bind directly to the delta domain of c-Jun in resting cells: implications for repression of c-Jun function. Oncogene 1995, 10:849-855.
7. Gupta S, Barrett T, Whitmarsh AJ, Cavanagh J, Sluss HK, Derijard B, Davis RJ: Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J 1996, 15:2760-2770.
8. Smeal T, Hibi M, Karin M: Altering the specificity of signal transduction cascades: positive regulation of c-Jun transcriptional activity by protein kinase A. EMBO J 1995, 13:6006-6010.
9. Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA, Ahmad MF, et al.: The stress-activated protein kinase subfamily of c-Jun kinases. Nature 1994, 369:156-160.
10. Van M, Dai T, Deak JC, Kyriakis JM, Zon LI, Woodgett JR, Templeton DJ: Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1. Nature 1994, 372:798-800.
11. Claret FX, Hibi M, Dhut S, Toda T, Karin M: A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Nature 1996, 383:453-457.
12. Karin M, Li Z, Zandi E: AP-1 function and regulation. Curr Opin Cell Biol 1997, 9:240-246.
13. Kilbey A, Black EJ, Unlu M, Gillespie DAF: The v-Jun oncoprotein replaces p39 c-Jun as the predominant AP-1 constituent in ASV17-transformed fibroblasts: implications for SAPK/ JNK-mediated signal transduction. Oncogene 1996, 12:2409-2418.
14. Castellazzi M, SpyrouG , La Vista N, DangyJ, Piu F, Yaniv M, Brun G: Overexpression of c-jun, junB, or junD affects cell growth differently. Proc Natl Acad Sci USA 1991, 88:8890-8894.
15. Gao M, Morgan I, Vogt PK: Differential and antagonistic effects of v-Jun and c-Jun. Cancer Res 1996, 56:4229-4235.
16. Angel P, Imagawa M, Chiu R, Stein B, Imbra RJ, Rahmsdorf HJ, et al.: Phorbol ester-inducible genes contain a common cis element recognised by a TPA-modulated trans-acting factor. Cell 1987, 49:729-739.
17. Franza BR, Josephs SF, Gilman MZ, Ryan W, Clarkson B: Characterization of cellular proteins recognizing the HIV enhancer using a microscale DNA-affinity precipitation assay. Nature 1987, 330:391-395.
18. Minden A, Lin A, Smeal T, Derijard B, Cobb M, Davis R, Karin M: c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases. Mol Cell Biol 1994, 14:6683-6688.
19. Minden A, Lin A, McMahon M, Lange-Carter C, Derijard B, Davis RJ,et al.: Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK.Science 1994, 266:1719-1723.
20. Zanke BW, Boudreau K, Rubie E, Winnet E, Tibbles A, Zon L, et al.: The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat. Curr Biol 1996, 6:606-613.
21. Bohman D, Tjian R: Biochemical analysis of transcriptional activation by Jun: differential activity of c-and v-Jun.Cell 1989, 59:709-717.
22. Baichwal VR, Tjian R: Control of c-Jun activity by interaction of a cell-specific inhibitor with regulatory domain delta: differences between v- and c-Jun. Cell 1990, 63:815-825.
23. Havarstein LS, Morgan IM, Wong W, Vogt PK: Mutations in the Jun Delta region suggest an inverse correlation between transformation and transcriptional activation. Proc Natl Acad Sci USA 1992, 89:618-622.
24. Sap J, Munoz A, Schmitt J, Stunnenberg H, Vennstrom B: Repression of transcription mediated at a thyroid hormone response element by the v-erb-A oncogene product. Nature 1989, 340:242-244.
25. Bartel P, Chien C, Sternglanz R, Fields S: Elimination of false positives that arise in using the two-hybrid system. Biotechniques 1993, 14:920-924.
26. Mumberg D, Muller R, Funk M: Regulatable promoters of Saccharomyces cerevisiae: comparison of transcriptional activity and their use for heterologous expression. Nucleic Acids Res 1994, 22:5767-5768.
27. Whitmarsh AJ, Shore P, Sharrocks AD, Davis RJ: Integration of MAP kinase signal transduction pathways at the serum response element. Science 1995, 269:403-407.